Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Breakthrough Cholesterol Drugs Fizzle Amid Price Pushback

April 20, 2016 3:04 pm | by Matthew Perrone, AP Health Writer | News | Comments

When a powerful pair of cholesterol-lowering drugs first hit the market last summer, initial excitement in the medical community quickly turned to panic.


Cellular Trojan Horse Yields Potential Cancer Treatment

April 20, 2016 1:58 pm | by Brigham and Women's Hospital | News | Comments

Prostate cancer tumors are characterized by a mixed cell population, which makes targeting the different kinds of cells with one treatment very difficult.


Toward a Resistance Proof Antiviral That Can Treat Many Diseases

April 20, 2016 1:53 pm | by American Chemical Society | News | Comments

Scientists and health officials are marshalling forces to fight Zika, the latest in a string of recent outbreaks.


Stand Up To Cancer Supports Innovative Research Grants for 10 Early-Career Scientists

April 20, 2016 9:25 am | by American Association for Cancer Research | News | Comments

Stand Up To Cancer (SU2C) announced Monday that it is awarding 10 grants of $750,000 each to early-career scientists to support innovative, high-risk, high-reward projects in cancer research. The announcement was made at the 2016 Annual Meeting of the American Association for Cancer Research, SU2C’s Scientific Partner.


Slight Increase in Norwegian Drug Consumption in 2015

April 20, 2016 9:10 am | by Norwegian Institute of Public Health | News | Comments

Drug sales measured in defined daily doses (DDD) increased by 2 percent from 2014 to 2015. Revenue growth was 8.6 percent. This is shown in "Drug Consumption in Norway 2011-2015," a report issued by the Norwegian Institute of Public Health.


NICE Recommends PTC's Duchenne Muscular Dystrophy Drug

April 20, 2016 8:59 am | News | Comments

The drug has been called a ‘step change’ in the management of the disease which causes progressive muscle wasting and is usually fatal by age 30.


Nanoparticle Acts like Trojan Horse to Halt Asthma

April 20, 2016 8:59 am | by Northwestern University | News | Comments

The technology can be applied to food allergies as well.


AbbVie, University of Chicago Announce Cancer Research Collaboration

April 20, 2016 8:46 am | News | Comments

Both organizations will work together to advance research in several areas of oncology.


Positive Phase 1 Data Announced for Ebola Vaccine Regimen

April 20, 2016 8:40 am | News | Comments

The Phase 1 study tested a vaccine regimen containing two components.


Pandemic E. Coli Strain H30 Cloaks Its Stealth Strategies

April 20, 2016 8:36 am | by UW Medicine | News | Comments

The bacterium E. coli comes in many different varieties.


Merck’s Keytruda Shows Promise for Merkel Cell Carcinoma

April 19, 2016 4:20 pm | by Stephanie Guzowski, Editor | News | Comments

The immunotherapy trend continues at this year’s American Association for Cancer Research (AACR) annual meeting in New Orleans.


Drug Target in Rare, Lethal Glandular Cancer Discovered

April 19, 2016 3:21 pm | by Yale University | News | Comments

New data shows that ACC and similar cancers could be treated with already available drugs.


Scientists Propose Treatment for Severe Lung Diseases

April 19, 2016 3:14 pm | by Cincinnati Children's Hospital Medical Center | News | Comments

Researchers are following up their current study with further development of the targeted small molecule they recently discovered.


UnitedHealth Ups 2016 Outlook after Surprisingly Strong 1Q

April 19, 2016 2:44 pm | by Tom Murphy, AP Business Writer | News | Comments

UnitedHealth hiked its 2016 forecast after the nation's largest health insurer topped Wall Street's first-quarter earnings expectations.


Research Opens Door for Monocyte-Based Cell Therapy

April 19, 2016 2:41 pm | by VIB | News | Comments

Using a mouse model for pulmonary alveolar proteinosis, the authors demonstrate that this rare disease can be cured by a single transfer of monocytes.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.